Biotest GmbH KGaA (LTS:0N6Z) EBITDA Margin %: 0.00% (As of . 20)


What is Biotest GmbH KGaA EBITDA Margin %?

Biotest GmbH KGaA LTS:0N6Z EBITDA Margin % is 0.00% as of . 20.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Biotest GmbH KGaA's EBITDA for the six months ended in . 20 was £0.00 Mil. Biotest GmbH KGaA's Revenue for the six months ended in . 20 was £0.00 Mil. Therefore, Biotest GmbH KGaA's EBITDA margin for the quarter that ended in . 20 was 0.00%.

Biotest GmbH KGaA  (LTS:0N6Z) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Biotest GmbH KGaA EBITDA Margin % Related Terms

Biotest GmbH KGaA EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Biotest GmbH KGaA's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotest GmbH KGaA EBITDA Margin % Chart

Biotest GmbH KGaA Annual Data
Trend
EBITDA Margin %

Biotest GmbH KGaA Semi-Annual Data
EBITDA Margin %

LTS:0N6Z vs : EBITDA Margin % Comparison

For the Biotechnology subindustry, Biotest GmbH KGaA's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotest GmbH KGaA EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biotest GmbH KGaA's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Biotest GmbH KGaA's EBITDA Margin % falls into.


Biotest GmbH KGaA EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Biotest GmbH KGaA's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

Biotest GmbH KGaA's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Biotest GmbH KGaA (LTS:0N6Z) has a EBITDA Margin % of 0.00% as of . 20. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Biotest GmbH KGaA and its competitors.
Is Biotest GmbH KGaA's EBITDA Margin % too high?
Biotest GmbH KGaA's current EBITDA Margin % is 0.00%.
How does Biotest GmbH KGaA's EBITDA Margin % compare to ?
Biotest GmbH KGaA's EBITDA Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Biotest GmbH KGaA and its competitors. Biotest GmbH KGaA's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biotest GmbH KGaA stock overvalued right now?
Biotest GmbH KGaA (LTS:0N6Z) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Biotest GmbH KGaA (LTS:0N6Z), the current EBITDA Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biotest GmbH KGaA Business Description

Comparable Companies
Biotest GmbH & Co KGaA is a specialist in haematology, clinical immunology, and intensive care medicine. The group develops, manufactures, and markets plasma proteins and biotherapeutic drugs. The group's value chain extends from pre-clinical and clinical development to world-wide marketing and distribution. It manufactures immunoglobulins, clotting factors, and albumins, which are derived from human blood plasma. The group markets its products in Europe, the Middle East, China, Australia, Africa, and the USA.